Home » Tenders » Asia » Sri Lanka » Abciximab for Intravenous Infusion 10mg/5ml Tender, Sri Lanka - 102515044

Abciximab for Intravenous Infusion 10mg/5ml Tender, Sri Lanka - 102515044

STATE PHARMACEUTICALS CORPORATION OF SRI LANKA has floated a tender for Abciximab for Intravenous Infusion 10mg/5ml. The project location is Sri Lanka and the tender is closing on 18 Jul 2024. The tender notice number is DHS/P/WW/233/24, while the TOT Ref Number is 102515044. Bidders can have further information about the Tender and can request the complete Tender document by Registering on the site.

Procurement Summary

Country : Sri Lanka

Summary : Abciximab for Intravenous Infusion 10mg/5ml

Deadline : 18 Jul 2024

Other Information

Notice Type : Tender

TOT Ref.No.: 102515044

Document Ref. No. : DHS/P/WW/233/24

Competition : ICB

Financier : Self Financed

Purchaser Ownership : Public

Tender Value : Refer Document

Purchaser's Detail

Name :Login to see tender_details

Address : Login to see tender_details

Email : Login to see tender_details

Tender Details

Tenders are invited for 600 Vials of Abciximab for Intravenous Infusion 10mg/5ml vial.

Abciximab for Intravenous Infusion 10mg in 5ml
vial.
Each 5ml vial to contain 10mg of Abciximab for
intravenous infusion.
Note:
1.This injection should be stable for minimum of
2 years when stored within 2'C - 8'C.
2.Each vial should be labelled accordingly

The amount of Bid Bond: LKR 960, 960.00 or USD 3, 199

Bid Bond should be submitted with valid up to 13.02.2025 together with the bid Bid should be valid till 14.01.2025.

Non refundable Bid Fee Rs.12, 500/= + Taxes should be paid in cash to SPC for each set of
Tender Documents.

Procurement Method: NCB Single Stage One Envelope

Geographic Location: Multiple Locations

Bid Closing Date & Time: 2024-07-18 09:00:00
Bidding Process Start: 2024-06-10 12:15:00
Bid Closing: 2024-07-18 09:00:00